CONMED Corporation (NASDAQ:CNMD): Going Behind the Numbers

Keeping an eye on shares of CONMED Corporation (NASDAQ:CNMD), we see that the current average price target is $62.5. Wall Street analysts have the ability to produce price target estimates for where they think the stock is heading. Because price target projections vary from one analyst to another, they may span a wide range of values. Many investors choose to monitor target prices, and they will pay extra close attention when there are updates. Investors might choose to lean heavily on analyst reports and target projections when doing their own stock research.

When it comes to investing in stocks, the question of risk will eventually need to be addressed. Of course, there are no guarantees when investing in the stock market. With this in mind, investors can proceed with a plan that helps minimize risk while still providing the opportunity to experience large profit potential. Each investor may have a different financial situation or tolerance for risk. There is often a fine line between being too aggressive or too conservative with equity investments. Finding that balance between the two extremes may be exactly what the earnest investor strives to do when tackling the markets.

Looking at some recent stock price activity for CONMED Corporation (NASDAQ:CNMD), we have spotted shares trading near the $60.09 level. Looking at some popular historical levels, we note that the 52-week high is presently $63.35, and the 52-week low is currently $40.11. When the stock is trading close to the 52-week high or 52-week low, investors may pay extra attention to see if there will be a move through that level. Looking back over the last 12 weeks, the stock has moved 15.74%. Heading back to the start of the year, we can see that shares have moved 17.89%. Over the past 4 weeks, shares have seen a change of 7%. Over the last 5 trading sessions, the stock has moved -5.15%.

Covering analysts are looking for CONMED Corporation (NASDAQ:CNMD) to report a current quarter EPS of 0.43 when the company issues their next earnings report. This is the consensus estimate using analysts taken into consideration by Zacks Research. This estimate includes 4 sell-side analysts. For the previous reporting period, the company posted a quarterly EPS of 0.69. Investors will be closely tracking how close the actual comes to the consensus estimate. Analysts covering the stock are usually very busy during earnings periods. Before the release, they might be revising estimates. After the earnings release, they will closely review the information and update accordingly.

Street analysts often provide stock recommendations for companies that they track. According to analysts polled by Zacks Research, the current average rating on shares of CONMED Corporation (NASDAQ:CNMD) is 2.4. This average rating includes analysts who have given Buy, Sell and Hold ratings on the name. This rating uses a numerical scale from 1 to 5. A 1 would indicate a Buy recommendation, and a score of 5 would point to a Sell recommendation. Out of all the analysts offering recommendations, 2 have rated the stock a Strong Buy or Buy.